Skip to content

Homoeopathy medicine for Ovulation

Efficacy of Folliculinum 6C as adjunctive to Individualized homoeopathic medicine Vs. Individualized homoeopathic medicine in the management of anovulatory Polycystic ovary syndrome infertile women â?? A double-blind Randomized Placebo controlled trial. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055378
Enrollment
84
Registered
2023-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Group A Add on Folliculinum 6C with Individualized Homoeopathic medicine: Folliculinum 6c twice in a day from day 6 onwards for up to 12 days or stopped when occurrence of ovulation i

Sponsors

Dr.R.Bhuvaneswari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married Female patients of reproductive age from 18 to 40 years. Patients having active married life minimum 1 year (or six months if a woman is 35 or older) with having anovulatory cycle. 2. PCOS with at least 2 of diagnostic criteria. A. Oligo/amenorrhea, anovulation (Inter-menstrual period of more than 35 days for 3 consecutive cycles)/amenorrhea for more than 3 months). B. Clinical evidence of Acne/Hirsutism/alopecia. C. Polycystic ovaries appearance on ultrasound (PCOS should have at least one of the following: either 12 or more follicles measuring 2+- mm in diameter or increased ovarian volume ( >10 cm3). Only one ovary fitting this definition or a single occurrence of one of the above criteria is sufficient to define the PCO. 3. Normal Pelvic USG 4. No recent treatment for Ovulation Induction. 5. Already confirmed diagnosis of anovulatory female 6. Primary and secondary both types of infertile patients have anovulatory cycle or with immature ovarian follicle

Exclusion criteria

Exclusion criteria: 1. Female who have structural deformity preventing fertility 2. Congenital anatomical defect. 3. Uncontrolled systemic disease like Diabetes mellitus, Hypertension, cardiac disease, renal diseases etc. 4. BMI > 35Kg/m2 5. Unexplained infertility

Design outcomes

Primary

MeasureTime frame
Primary outcome of the study is comparing the proportion of occurrence of Ovulation at the end of 9 months between Folliculinum 6C add on Individualized homoeopathic medicine & Individualized homoeopathic medicine alone using chi square test. Significant level p 0.05. Timepoint: End of 9 months

Secondary

MeasureTime frame
1. To assess the improvement in associated clinical symptoms like menstrual abnormalities, dysmenorrhea, scanty menstrual bleeding, & irregular menses. 2. Establishment of Urine pregnancy test positive. 3. To compare the clinical changes in acne (acne global severity scale score 1 and above) 4. To compare Improvement in Hirsutism Timepoint: End of 9 months

Countries

India

Contacts

Public ContactDr Rajitha KNair

Dept. of Repertory, Govt. Homoeopathic Medical College, Trivandrum

rajithaknair@yahoo.com9747148672

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026